SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-026522
Filing Date
2021-02-03
Accepted
2021-02-03 08:31:00
Documents
12
Period of Report
2021-02-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d108902d8k.htm   iXBRL 8-K 23496
  Complete submission text file 0001193125-21-026522.txt   141722

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cort-20210203.xsd EX-101.SCH 3065
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20210203_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20210203_pre.xml EX-101.PRE 10949
5 EXTRACTED XBRL INSTANCE DOCUMENT d108902d8k_htm.xml XML 3279
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 21584429
SIC: 2834 Pharmaceutical Preparations